REMINDER: Zealand Pharma’s Capital Markets Day on December 11, 2025

About this update from Zealand Pharma A/s

Press release – No. 17 / 2025 REMINDER: Zealand Pharma’s Capital Markets Day on December 11, 2025 Copenhagen, Denmark, December 1, 2025 - Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company focused on the discovery and development of innovative peptide-based medicines, is hosting a Capital Markets Day in London on December 11, 2025, featuring presentations from management and external experts in obesity and metabolism. Time: December 11, 2025, from 1.00-5.30pm GMT (2.00-6.30pm CET) Venue: Goldman Sachs International, Plumtree Court, 2 Stonecutter Street, London EC4A 4AU Register for in-person or virtual attendance : Registration | Zealand Pharma Capital Markets Day A replay of the webcast will be archived on the company’s website following the presentation. Zealand Pharma speakers: External experts: About Zealand Pharma Zealand Pharma A/S (Nasdaq: ZEAL) is a biotechnology company focused on the discovery and development of peptide-based medicines. More than 10 drug candidates invented by Zealand Pharma have advanced into clinical development, of which two have reached the market and three candidates are in late-stage development. The company has development partnerships with a number of pharma companies as well as commercial partnerships for its marketed products. Zealand Pharma was founded in 1998 and is headquartered in Copenhagen, Denmark, with a presence in the U.S. For more information about Zealand Pharma’s business and activities, please visit www.zealandpharma.com . Contacts Adam Lange (Investors) Vice President, Investor Relations Zealand Pharma Email: [email protected] Neshat Ahmadi (Investors) Investor Relations Manager Zealand Pharma Email: [email protected] Rachel James-Owens (Media) Vice President, Corporate Communications and Media Relations Zealand Pharma [email protected] Amber Fennell, Jessica Hodgson, Sean Leous (Media) ICR Healthcare [email protected] +44 (0) 7739 658 783

View stock analysis, news, and events for Zealand Pharma A/s